A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
The overexpression of the A<sub>3</sub> adenosine receptor (AR) in a number of cancer cell types makes it an attractive target for tumor diagnosis and therapy. Hence, in the search for new A<sub>3</sub>AR ligands, a series of novel 2,<i>N</i><sup>6</sup>-disubstituted adenosines (Ados) was synthesiz...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2022-01-01
|
| Серія: | Pharmaceuticals |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/1424-8247/15/2/164 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|